This study assessed the efficacy and safety of the 8-week administration of PTV/r/OBV/DSV in a real-world cohort of treatment-naive, HCV genotype 1b-infected patients with mild to moderate fibrosis
Liver International
Original Article: 8 Weeks of PTV/r/OBV/DSVin HCV With Mild-moderate Fibrosis